Ribozymes targeted to TNF-.alpha. RNA
US5616490A · kind A · utility
13Cited by
2References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 4, 1995 |
| Grant date | Apr 1, 1997 |
| Priority date | — |
| Expiry date | May 4, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/3535
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An enzymatic RNA molecule which cleaves mRNA associated with development or maintenance of an inflammatory disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.